---

Background and Objective: Parathyroid proteins involved in calcium homeostasis. With increasing age and other relevant factors, this hormone is not able to perform its role. Using recombinant parathyroid hormone prevent disease progression and effective in improvement of disease. This study was done to design and build the desired construct genes, cloning process and synthesis of soluble parathyroid hormone in E. coli. Methods: In this laboratory study, design and optimization sequence of the gene parathyroid hormone (PTH) was carried out for expression of soluble proteins in bacteria. The construct contining PTH gene (puc 57) transformed into bacteria and cultivation was done in SOB medium then Plasmid extraction was performed. Fragment encoding the PTH was isolated by digestion of the cloning vector and ligate to expression vector (PET-32a). Subcloning process followed by induction with IPTG 1mM. The recombinant parathyroid hormon was expressed in bacteria, subsequently. Results: After enzymatic digestion, the fragment encoding the protein of interest was properly localized. The process was confirmed by polymerase chain reaction (PCR). Following performing a transformation, induction process performed by IPTG with final concentration 1mM that caused the soluble parathyroid proteins to be expressed in bacteria and the process was confirmed by Western blot technique. Conclusion: Protein expression in bacteria due to its rapid growth and the need to inexpensive medium is cost-effective. Soluble recombinant protein expression reduces downstream of recombinant protein production.

---

Background and Objective: Calcitonin is a small peptide hormone including 32 amino acids and 3.4 KD molecular weight which is produced by the parafollicular cells of the thyroid gland in respond to increasing calcium ions in serum. This peptide is used for adjuvant therapy of osteoporosis, Paget's disease and hypercalcemic shock. In this study, the heterologuse expression of calcitonin was done in Escherichia coli.

Methods: In this experimental study, the thioredoxin fusion partner was added to n-terminal of the Salmon calciton in order to increase its stability by the synthetic biology. The recombinant construct was transformed and over expressed into Escherichia coli BL21 (DE3) host cell.

Results: SDS-PAGE analysis showed the over expression of recombinant protein after IPTG induction.

Conclusion: In this study, the construct including fused Salmon calcitonin gene with thioredoxin was cloned. The SDS-PAGE result showed the stable expression of fused calcitonin.

---

Background and Objective: Granulocyte colony-stimulating factors (G-CSF) and its receptor express in developing follicles, fetal and reproductive tissues. The serum G-CSF concentration significantly increases during the ovulatory phase in comparison with other phases, so G-CSF may have an important role in ovulation and the early cross-talk between mother and conceptus in both human and animal models. This study was done to evaluate the Effect of exogenous G-CSF on ovulation and pregnancy rate in NMRI mice.

Methods: In this experimental study, 40 mature female and 10 male NMRI mice were randomly allocated into the control and treatment groups. All Ovaries were stimulated with intraperitoneal injections (IP) of 10 IU PMSG and after 48 hour by 10 IU hCG per mouse. The treatment group were recieved G-CSF (50mg/kg i.p.), at the time of PMSG administration, while the control group had the same volume of normal saline instead of G-CSF at the same time. 16-18 hours post-hCG administration, twenty female mice of both groups were sacrificed by cervical dislocation and ovulated oocytes were assessed. On day 16 post coitus, the rest of female mice of both groups were scarificed for withdrawing their fetuses to determine the effect of G-CSF on pregnancy rates.

Results: The ovulation rate in the treatment group (18.5±1.25) were significantly more than that of control (12.1±1.32) (P<0.05). The number of fetuses had no significant difference between control and treatment groups.

Conclusion: This study demonstrated that exogenous G-CSF may affect on folliculogenesis and ovulation but the following pregnancy outcome was not impressed.

---

Background and Objective: Copper oxide nanoparticles with unique properties have numerous biological applications with probably toxicity. This study was conducted to determine the toxicity of copper oxide nanoparticles on the pituitary-gonadal axis and spermatogenesis in male rats.
Methods: In this experimental study, 40 male Wistar rats were randomly allocated into 4 groups including control group and three intervention  groups which receiving the cancentration of 10, 20 and 30 mg/kg of copper oxide nanoparticles 5 times intra-peritoneally, respectively. Blood sampling was collected first day and 15 days after the last injection. Level of testosterone, FSH and LH were measured by ELISA method. After anesthesia and dissection of mice in each group, tissue sections of testis were prepared and stained with hematoxylin-eosin. Morphological status of spermatogenesis process and counting of types of cells (spermatogonium, spermatocyte and spermatid) were studied by optical microscope.
Results: In the first day of blood collection, a significant increase in LH and FSH level was observed at concentrations of 10 and 30 mg/kg, respectively. Also, Testosterone and FSH level decreased significantly reduced at 10 mg/kg/bw concentration compared to control (P<0.05). In 15 days after of the last injection, level of testosterone (P<0.05) and LH (P<0. 05) significantly increased in concentrations of 10 and 30 mg/kg/bw respectively. Also, there was a significant reduction in level of FSH in the concentration of 10 mg/kg/bw (P<0.05). The examination of testis tissue sections showed a significant decrease (P<0.05) in density and number of cell types (spermatogonium, spermatocyte and spermatid) and anomalies in the spermatogenesis process, in a dose-dependent manner. The most disturbances was seen at a concentration of 30 mg/kg/bw of copper oxide nanoparticles.
Conclusion: Copper oxide nanoparticles may interfere with the secretion of gonadotropins and testosterone and ultimately lead to a disruption of the spermatogenesis process.

---

Background and Objective: Copper oxide nanoparticles, in addition to useful applications, may have adverse effects on the organisms.This study was done to determine the effect of copper oxide nanoparticles on liver toxicity, enzymes changes and liver histological structure of rats.
Methods: In this experimental study, 40 Wistar male rats were randomly allocated into 4 groups. During 10 days, five times (one day interval), 3 groups of rats were received 10, 20 and 30 mg/kg of copper oxide nanoparticles with a diameter of less than 50 nm and purity of 99% and a surface of 80 m²/g intraperitoneally, respectively. One group was considered as the control group. Activity of Lactate dehydrogenase (LDH), Alkaline phosphatase (ALP), Aspartate transaminase (AST) and Alanine aminotransferase (ALT) enzymes were tested in two stages (one day and 15 days after treatment). Also, liver tissue sections were prepared and stained with hematoxylin-eosin.
Results: No significant alterations of AST enzyme activity were not seen between different groups in two stages. The activity of ALT, ALP, and LDH enzymes in the first stage showed a significant increase in all treatment groups compared to control and returned to normal after 15 days. Rat's weight changes were not statistically significant between different groups. Histological studies revealed multiple tissue injuries in dose-dependent in treatment groups which included mild and severe hyperemia, hepatocytes degeneration, hyperplasia and inflammation.
Conclusion: Injection of low doses of copper oxide nanoparticles, after 15 days, although changes in enzyme activity return to normal, but significant disturbances observes in the structure of the liver tissue.

---

Background and Objective: Molybdenum trioxide (MoO₃) is a type of nanoparticle used in the industry as an antibacterial agent. The kidney is one of the most important organs in the body, responsible for filtering waste products and regulating blood factors that are affected by various agents. Due to the widespread use of MoO₃ in disinfecting operating room equipment and the importance of renal glomeruli in blood plasma purification, this study aimed to determine the effect of molybdenum trioxide nanoparticles on rat kidneys.
Methods: In this experimental study, thirty Wistar rats weighing 250-300 g were randomly divided into five groups (n=6), including a control group, a sham group (receiving normal saline), and three experimental groups (receiving MoO₃ at doses of 50, 100, and 200 mg/kg/bw IP). Intraperitoneal injections were given for 35 days. After the treatment period, the animals were anesthetized, and blood samples were collected from the heart. The right kidney was then removed, and after tissue preparation, the samples were examined by stereology to determine changes in the volume of cortex, medulla, urinary space, renal body, and glomeruli.
Results: Significant increases in urinary space volume were observed in the groups receiving MoO₃, and a decrease in medulla volume was observed in the group receiving a dose of 200 mg/kg/bw compared to the control and sham groups (P<0.05). A significant increase in cortex volume was observed in the group receiving nanoparticles at a dose of 50 mg/kg/bw compared to the control and sham groups. MoO₃ caused weight reduction in animals, as well as an increase in urea and a decrease in renal volume (P<0.05).
Conclusion: Molybdenum trioxide nanoparticles can cause changes in the morphology of rats' kidneys.